BioFactura's Incubator/Accelerator Round

BioFactura raised a round of funding on , . Investors include Frederick Innovative Technology Center.

BioFactura develops and commercializes biodefense drugs, client-selected novel drugs, and high-value biosimilars (i.e., follow-on biologics or generic biopharmaceuticals) using its patented StableFast…

Articles about BioFactura's Incubator/Accelerator Round: